Limiting viral replication in hepatocytes alters Rift Valley fever virus disease manifestations.
J Virol.
2023 Sep 28;97(9):e0085323. doi: 10.1128/jvi.00853-23. Epub 2023 Sep 11. PubMed PMID:
37695055; PubMed Central PMCID:
PMC10537571.
Impact of maternal SARS-CoV-2 booster vaccination on blood and breastmilk antibodies.
PLoS One.
2023;18(6):e0287103. doi: 10.1371/journal.pone.0287103. eCollection 2023. PubMed PMID:
37310982; PubMed Central PMCID:
PMC10263312.
Human Metapneumovirus Reinfection in Aged Mice Recapitulates Increased Disease Severity in Elderly Humans Infected with Human Metapneumovirus.
Immunohorizons.
2023 Jun 1;7(6):398-411. doi: 10.4049/immunohorizons.2300026. PubMed PMID:
37261717; PubMed Central PMCID:
PMC10321313.
Immune correlates of protection following Rift Valley fever virus vaccination.
NPJ Vaccines.
2022 Oct 28;7(1):129. doi: 10.1038/s41541-022-00551-4. PubMed PMID:
36307416; PubMed Central PMCID:
PMC9616434.
Rift Valley Fever Virus Infects the Posterior Segment of the Eye and Induces Inflammation in a Rat Model of Ocular Disease.
J Virol.
2022 Oct 26;96(20):e0111222. doi: 10.1128/jvi.01112-22. Epub 2022 Oct 4. PubMed PMID:
36194021; PubMed Central PMCID:
PMC9599513.
Genetic diversity of collaborative cross mice enables identification of novel rift valley fever virus encephalitis model.
PLoS Pathog.
2022 Jul;18(7):e1010649. doi: 10.1371/journal.ppat.1010649. eCollection 2022 Jul. PubMed PMID:
35834486; PubMed Central PMCID:
PMC9282606.
Comparative analysis of human immune responses following SARS-CoV-2 vaccination with BNT162b2, mRNA-1273, or Ad26.COV2.S.
NPJ Vaccines.
2022 Jul 6;7(1):77. doi: 10.1038/s41541-022-00504-x. PubMed PMID:
35794181; PubMed Central PMCID:
PMC9258461.
A Mycobacteriophage-Based Vaccine Platform: SARS-CoV-2 Antigen Expression and Display.
Microorganisms.
2021 Nov 23;9(12). doi: 10.3390/microorganisms9122414. PubMed PMID:
34946016; PubMed Central PMCID:
PMC8704799.
Identification and Characterization of Rift Valley Fever Virus-Specific T Cells Reveals a Dependence on CD40/CD40L Interactions for Prevention of Encephalitis.
J Virol.
2021 Nov 9;95(23):e0150621. doi: 10.1128/JVI.01506-21. Epub 2021 Sep 8. PubMed PMID:
34495703; PubMed Central PMCID:
PMC8577384.
SARS-CoV-2 Antibody Response is Associated with Age in Convalescent Outpatients.
medRxiv.
2021 Nov 8;. doi: 10.1101/2021.11.08.21265888. PubMed PMID:
34790986; PubMed Central PMCID:
PMC8597889.
Multiplex assessment of SARS-CoV-2 antibodies improves assay sensitivity and correlation with neutralizing antibodies.
Clin Biochem.
2021 Nov;97:54-61. doi: 10.1016/j.clinbiochem.2021.08.006. Epub 2021 Aug 26. PubMed PMID:
34453893; PubMed Central PMCID:
PMC8387133.
Isotype-Specific Fc Effector Functions Enhance Antibody-Mediated Rift Valley Fever Virus Protection In Vivo.
mSphere.
2021 Oct 27;6(5):e0055621. doi: 10.1128/mSphere.00556-21. Epub 2021 Sep 8. PubMed PMID:
34494884; PubMed Central PMCID:
PMC8550229.
Lrp1 is a host entry factor for Rift Valley fever virus.
Cell.
2021 Sep 30;184(20):5163-5178.e24. doi: 10.1016/j.cell.2021.09.001. Epub 2021 Sep 23. PubMed PMID:
34559985; PubMed Central PMCID:
PMC8786218.
A Cross-Sectional Study of SARS-CoV-2 Seroprevalence between Fall 2020 and February 2021 in Allegheny County, Western Pennsylvania, USA.
Pathogens.
2021 Jun 6;10(6). doi: 10.3390/pathogens10060710. PubMed PMID:
34204122; PubMed Central PMCID:
PMC8226606.
SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients.
J Gen Virol.
2020 Nov;101(11):1156-1169. doi: 10.1099/jgv.0.001481. Epub 2020 Aug 21. PubMed PMID:
32821033; PubMed Central PMCID:
PMC7879561.
Rift Valley Fever Virus Infection Causes Acute Encephalitis in the Ferret.
mSphere.
2020 Oct 28;5(5). doi: 10.1128/mSphere.00798-20. PubMed PMID:
33115835; PubMed Central PMCID:
PMC7593599.
Severe Human Lassa Fever Is Characterized by Nonspecific T-Cell Activation and Lymphocyte Homing to Inflamed Tissues.
J Virol.
2020 Oct 14;94(21). doi: 10.1128/JVI.01367-20. Print 2020 Oct 14. PubMed PMID:
32817220; PubMed Central PMCID:
PMC7565638.
Animal models for COVID-19.
Nature.
2020 Oct;586(7830):509-515. doi: 10.1038/s41586-020-2787-6. Epub 2020 Sep 23. Review. PubMed PMID:
32967005; PubMed Central PMCID:
PMC8136862.
SARS-CoV-2 infection of African green monkeys results in mild respiratory disease discernible by PET/CT imaging and shedding of infectious virus from both respiratory and gastrointestinal tracts.
PLoS Pathog.
2020 Sep;16(9):e1008903. doi: 10.1371/journal.ppat.1008903. eCollection 2020 Sep. PubMed PMID:
32946524; PubMed Central PMCID:
PMC7535860.
Dynamics of human B and T cell adaptive immune responses to Kyasanur Forest disease virus infection.
Sci Rep.
2020 Sep 17;10(1):15306. doi: 10.1038/s41598-020-72205-1. PubMed PMID:
32943687; PubMed Central PMCID:
PMC7499197.
Rift Valley Fever Virus Is Lethal in Different Inbred Mouse Strains Independent of Sex.
Front Microbiol.
2020;11:1962. doi: 10.3389/fmicb.2020.01962. eCollection 2020. PubMed PMID:
32973712; PubMed Central PMCID:
PMC7472459.
Prospective Cohort Study of Next-Generation Sequencing as a Diagnostic Modality for Unexplained Encephalitis in Children.
J Pediatric Infect Dis Soc.
2020 Jul 13;9(3):326-333. doi: 10.1093/jpids/piz032. PubMed PMID:
31107955; PubMed Central PMCID:
PMC7457329.
Immunologic timeline of Ebola virus disease and recovery in humans.
JCI Insight.
2020 May 21;5(10). doi: 10.1172/jci.insight.137260. PubMed PMID:
32434986; PubMed Central PMCID:
PMC7259516.
Rift Valley fever virus vaccination induces long-lived, antigen-specific human T cell responses.
NPJ Vaccines.
2020;5(1):17. doi: 10.1038/s41541-020-0166-9. eCollection 2020. PubMed PMID:
32140261; PubMed Central PMCID:
PMC7048758.
Fluorescent Crimean-Congo hemorrhagic fever virus illuminates tissue tropism patterns and identifies early mononuclear phagocytic cell targets in Ifnar-/- mice.
PLoS Pathog.
2019 Dec;15(12):e1008183. doi: 10.1371/journal.ppat.1008183. eCollection 2019 Dec. PubMed PMID:
31790513; PubMed Central PMCID:
PMC6984736.
Adaptive Immune Responses in Humans During Nipah Virus Acute and Convalescent Phases of Infection.
Clin Infect Dis.
2019 Oct 30;69(10):1752-1756. doi: 10.1093/cid/ciz010. PubMed PMID:
30615097.
Characterization of Virus-specific Immune Response During Varicella Zoster Virus Encephalitis in a Young Adult.
Clin Infect Dis.
2019 Jul 2;69(2):348-351. doi: 10.1093/cid/ciy984. PubMed PMID:
30668661; PubMed Central PMCID:
PMC7322817.
Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection.
Cell.
2019 May 30;177(6):1566-1582.e17. doi: 10.1016/j.cell.2019.04.036. Epub 2019 May 16. PubMed PMID:
31104840; PubMed Central PMCID:
PMC6908968.
Ebola virus disease.
Lancet.
2019 Mar 2;393(10174):936-948. doi: 10.1016/S0140-6736(18)33132-5. Epub 2019 Feb 15. Review. PubMed PMID:
30777297.
Macrophage Activation Marker Soluble CD163 Associated with Fatal and Severe Ebola Virus Disease in Humans(1).
Emerg Infect Dis.
2019 Feb;25(2):290-298. doi: 10.3201/eid2502.181326. PubMed PMID:
30666927; PubMed Central PMCID:
PMC6346465.
CD4 T Cells, CD8 T Cells, and Monocytes Coordinate To Prevent Rift Valley Fever Virus Encephalitis.
J Virol.
2018 Dec 15;92(24). doi: 10.1128/JVI.01270-18. Print 2018 Dec 15. PubMed PMID:
30258000; PubMed Central PMCID:
PMC6258944.
Human Biomarkers of Outcome Following Rift Valley Fever Virus Infection.
J Infect Dis.
2018 Oct 20;218(11):1847-1851. doi: 10.1093/infdis/jiy393. PubMed PMID:
29955891; PubMed Central PMCID:
PMC6455937.
Innate immune responses elicited by Sin Nombre virus or type I IFN agonists protect hamsters from lethal Andes virus infections.
J Gen Virol.
2018 Aug 1;. doi: 10.1099/jgv.0.001131. [Epub ahead of print] PubMed PMID:
30067171.
Human immune cell engraftment does not alter development of severe acute Rift Valley fever in mice.
PLoS One.
2018;13(7):e0201104. doi: 10.1371/journal.pone.0201104. eCollection 2018. PubMed PMID:
30028878; PubMed Central PMCID:
PMC6054394.
Rift valley fever viral load correlates with the human inflammatory response and coagulation pathway abnormalities in humans with hemorrhagic manifestations.
PLoS Negl Trop Dis.
2018 May;12(5):e0006460. doi: 10.1371/journal.pntd.0006460. eCollection 2018 May. PubMed PMID:
29727450; PubMed Central PMCID:
PMC5955566.
Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing.
mBio.
2018 May 1;9(3). doi: 10.1128/mBio.00660-18. PubMed PMID:
29717011; PubMed Central PMCID:
PMC5930306.
Encephalitis and Thalamic Injury From Neuroinvasive West Nile Virus in Children on Treatment for Acute Lymphoblastic Leukemia.
Pediatr Neurol.
2018 Mar;80:84-87. doi: 10.1016/j.pediatrneurol.2017.11.013. Epub 2017 Dec 2. PubMed PMID:
29398166.
Immune barriers of Ebola virus infection.
Curr Opin Virol.
2018 Feb;28:152-160. doi: 10.1016/j.coviro.2018.01.010. Epub 2018 Feb 16. Review. PubMed PMID:
29452995; PubMed Central PMCID:
PMC5886007.
Crimean-Congo Hemorrhagic Fever in Humanized Mice Reveals Glial Cells as Primary Targets of Neurological Infection.
J Infect Dis.
2017 Dec 12;216(11):1386-1397. doi: 10.1093/infdis/jix215. PubMed PMID:
28482001; PubMed Central PMCID:
PMC5853341.
Whole Blood-Based Multiplex Immunoassays for the Evaluation of Human Biomarker Responses to Emerging Viruses in Resource-Limited Regions.
Viral Immunol.
2017 Nov;30(9):671-674. doi: 10.1089/vim.2017.0088. Epub 2017 Sep 22. PubMed PMID:
28937957; PubMed Central PMCID:
PMC5672621.
Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever.
Clin Infect Dis.
2017 Sep 1;65(5):855-859. doi: 10.1093/cid/cix406. PubMed PMID:
29017278; PubMed Central PMCID:
PMC5682919.
A Case of Human Lassa Virus Infection With Robust Acute T-Cell Activation and Long-Term Virus-Specific T-Cell Responses.
J Infect Dis.
2017 Jun 15;215(12):1862-1872. doi: 10.1093/infdis/jix201. PubMed PMID:
28863472; PubMed Central PMCID:
PMC5853890.
First Newborn Baby to Receive Experimental Therapies Survives Ebola Virus Disease.
J Infect Dis.
2017 Jan 15;215(2):171-174. doi: 10.1093/infdis/jiw493. PubMed PMID:
28073857; PubMed Central PMCID:
PMC5583641.
Ebola Virus Disease in Humans: Pathophysiology and Immunity.
Curr Top Microbiol Immunol.
2017;411:141-169. doi: 10.1007/82_2017_11. Review. PubMed PMID:
28653186; PubMed Central PMCID:
PMC7122202.
Defining antigen-specific plasmablast and memory B cell subsets in human blood after viral infection or vaccination.
Nat Immunol.
2016 Oct;17(10):1226-34. doi: 10.1038/ni.3533. Epub 2016 Aug 15. PubMed PMID:
27525369; PubMed Central PMCID:
PMC5054979.
Kinetic Analysis of Biomarkers in a Cohort of US Patients With Ebola Virus Disease.
Clin Infect Dis.
2016 Aug 15;63(4):460-7. doi: 10.1093/cid/ciw334. Epub 2016 Jun 27. PubMed PMID:
27353663; PubMed Central PMCID:
PMC4967605.
Rift Valley fever virus: Unanswered questions.
Antiviral Res.
2016 Aug;132:274-80. doi: 10.1016/j.antiviral.2016.07.005. Epub 2016 Jul 9. Review. PubMed PMID:
27400990.
Ebola Virus Persistence in Semen of Male Survivors.
Clin Infect Dis.
2016 Jun 15;62(12):1552-1555. doi: 10.1093/cid/ciw202. Epub 2016 Apr 3. PubMed PMID:
27045122.
Relationship Between Ebola Virus Real-Time Quantitative Polymerase Chain Reaction-Based Threshold Cycle Value and Virus Isolation From Human Plasma.
J Infect Dis.
2015 Oct 1;212 Suppl 2(Suppl 2):S346-9. doi: 10.1093/infdis/jiv187. Epub 2015 May 3. PubMed PMID:
25941333; PubMed Central PMCID:
PMC4675930.
The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States.
Clin Infect Dis.
2015 Aug 15;61(4):496-502. doi: 10.1093/cid/civ334. Epub 2015 Apr 22. PubMed PMID:
25904375; PubMed Central PMCID:
PMC4542597.
What would you like to do?